When was Vivance founded?

Vivance was founded in 2010 and raised its 1st funding round 6 years after it was founded.

Where is Vivance located?

Vivance is headquartered in Magog, Canada. It is registered at WILKIE ROAD, Singapore, 228095.

Who is the current CEO of Vivance?

Suresha Venkataraya of Vivance.

Which legal entities is Vivance associated with?

Vivance is associated with VIVANCE PTE. LTD..

How many employees does Vivance have?

As of Sep 30, 2026, the latest employee count at Vivance is 143.

Is Vivance a funded company?

Vivance is a funded company, having raised a total of $71.2M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Dec 01, 2016.

When was the latest funding round of Vivance?

Vivance's latest funding was a $***** Series B round on Sep 13, 2023, with participation from 4 investors.

Where does Vivance rank among its competitors?

Vivance ranks 3rd amongst 15 active competitors, of which 7 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Simergent, which secured $1.67M in Dec, 2025.

Who are the top competitors of Vivance?

Vivance's top competitors include Simergent, Opterion and TrioMed. Among them, Simergent secured the most recent funding round in December, 2025.

Vivance - 2026 Company Profile, Team, Funding & Competitors

Vivance is a series B company based in Magog (Canada), founded in 2010. It operates as a Do Not Publish request by OD. Vivance has raised $71.2M in funding from investors like Vickers Venture Partners, MTA and Lion X Ventures. The company has 15 active competitors, including 7 that are funded. Its top competitors include companies like Simergent, Opterion and TrioMed.

Company Details

Do Not Publish request by OD

Website: vivance.com
Social
Registered Address: WILKIE ROAD, Singapore, 228095

Key Metrics

Founded Year

2010

Location

Magog, Canada

Stage

Series B

Total Funding

$71.2M in 3 rounds

Latest Funding Round

Series B, Sep 13, 2023, $*****

Investors

Vickers Venture Partners & 5 more

Ranked

3^rd among 15 active competitors

Employee Count

143 as on Sep 30, 2026

Similar Companies

Simergent & 15 more

View Vivance's full profile

Vivance is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
VIVANCE PTE. LTD. UEN: 200707436Z , Singapore, Active	Apr 30, 2007	-	-

Vivance has raised a total funding of $71.2M over 3 rounds. Its first funding round was on Dec 01, 2016. Its latest funding round was a Series B round on Sep 13, 2023 for $*****. 4 investors participated in its latest round. Vivance has 6 institutional investors.

Here is the list of recent funding rounds of Vivance:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 13, 2023	9514788	Series B	6235830	8209463	5883772	9142979
Dec 12, 2019	2833814	Series B	9887415	9700925	5478104	Advanced MedTech & 1 more
Dec 01, 2016	9855605	Series B	6831464	4386411	MTA	8445971

Access funding benchmarks and valuations. Sign up today!

View details of Vivance's funding rounds and investors

Vivance's employee count trend

Vivance has 143 employees as of Sep 26. Here is Vivance's employee count trend over the years:

Uncover Vivance's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Vivance include Simergent, Opterion and TrioMed. Here is the list of Top 10 competitors of Vivance, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Simergent 2014, Chicago (United States), Series A	Manufacturer of automated peritoneal dialysis system	$13M	i2E, MTT Ventures & 3 others	52/100
2nd	Opterion 2012, Sarnen (Switzerland), Series B	Developer of therapeutic solutions for the treatment of acute kidney diseases	$17.4M	Hemex, HEMEX	51/100
3rd	Vivance 2010, Magog (Canada), Series B	Do Not Publish request by OD	$71.2M	SEEDS Capital, Advanced MedTech & 4 others	44/100
4th	TrioMed 2005, Lund (Sweden), Series A	Developer of peritoneal dialysis system designed to improve treatment and outcomes	-	Almi Invest, KMG Capital Partners & 1 others	41/100
5th	Mitra Industries 1995, Faridabad (India), Unfunded	Developer of noncardiac stents and blood bags	-	-	39/100
6th	liberDi 2014, Or Akiva (Israel), Seed	Portable peritoneal dialysis systems for renal disorders	$1.13M	Intuition Fund, The Trendlines Group & 4 others	36/100
7th	Avyantra 2017, Hyderabad (India), Funding Raised	Developer of ML technology for neonatal diseases and automated peritoneal dialysis device	-	C-CAMP, BIRAC & 4 others	33/100
8th	Relavo 2020, Baltimore (United States), Funding Raised	Developer of dialysis devices for kidney failure patients	-	Pipeline Angels, Springboard Enterprises & 3 others	30/100
9th	Padmaseetha Technologies 2014, Chennai (India), Seed	Developer of connected devices for renal dialysis	-	CIE IIITH, RTBI & 6 others	30/100
10th	GlomeriaTherapeutics 2010, Chieti (Italy), Series A	Developing devices for treatment of nephropathy and cardiopathy	$1.13M	EIC Fund, Sofimac Investment Managers & 3 others	27/100